A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Assets under management requirements are becoming a high hurdle for early-career advisors looking for a new role.
A new division will connect the firms’ wealthiest clients with other products and services on the Bank of America platform.
Owning a Rolls-Royce is pretty good. But is it really that impressive when you could have a unique Rolls-Royce?